Nervous system damage in COVID-19 with an emphasis on the management of patients with multiple sclerosis

Por A. N. Boyko, S. A. Sivertseva, N. N. Spirin
Publicado em 2020-08-01

THE ROLE OF INFECTIOUS DISEASES IN THE DEVELOPMENT OF MULTIPLE SCLEROSIS IN NORTH OSSETIA – ALANIA REPUBLIC

Por E. I. Gusev, A. N. Boyko, M. A. Khodova, N. F. Smirnova, S. A. Sivertseva, A. V. Smirnov
Publicado em 2015-08-01

Recommendations from the Expert Meeting «Secondary progressive multiple sclerosis: unresolved issues and prospects»

Por N. V. Khachanova, A. N. Boyko, K. Z. Bakhtiyarova, Ya. V. Vlasov, E. P. Evdoshenko, S. A. Sivertseva, T. E. Schmidt, M. V. Shumilina
Publicado em 2019-12-01

Results of Expert Council meeting on modern principles of treatment optimization in patients with relapsing-remitting multiple sclerosis using anti-CD20 monoclonal antibody

Por A. N. Boyko, N. V. Khachanova, D. S. Korobko, D. S. Kasatkin, Ya. V. Vlasov, E. P. Evdoshenko, E. V. Popova, K. Z. Bakhtiyarova, S. A. Sivertseva
Publicado em 2021-06-01

New possibilities of siponimod therapy in patients with secondary progressive multiple sclerosis

Por D. S. Kasatkin, N. V. Khachanova, V. M. Alifirova, A. N. Boyko, K. Z. Bakhtiyarova, Ya. V. Vlasov, M. V. Davydovskaya, E. P. Evdoshenko, S. A. Sivertseva
Publicado em 2021-02-01

COVID-19 vaccination guidelines for patients with multiple sclerosis

Por N. V. Khachanova, N. A. Totolyan, Ya. V. Vlasov, S. A. Sivertseva, M. V. Davydovskaya, E. P. Evdoshenko, A. P. Prodeus, M. N. Zakharova, N. N. Spirin, A. N. Boyko
Publicado em 2021-04-01

Clinical recommendations for the use of ocrelizumab in patients with multiple sclerosis

Por A. N. Boyko, M. V. Davydovskaya, N. V. Khachanova, M. N. Zakharova, N. N. Spirin, E. V. Popova, V. M. Alifirova, Ya. V. Vlasov, S. A. Sivertseva, F. A. Khabirov, M. V. Shumilina, E. P. Evdoshenko
Publicado em 2019-11-01

Recommendations for the use of cladribine tablets for the pathogenetic treatment of patients with highly active multiple sclerosis

Por K. Z. Bakhtiyarova, A. N. Boyko, Ya. V. Vlasov, Z. A. Goncharova, M. V. Davydovskaya, M. N. Zakharova, N. A. Malkova, A. I. Nilov, S. A. Sivertseva, N. N. Spirin, N. A. Totolyan, F. A. Khabirov, M. V. Shumilina
Publicado em 2020-06-01

Recommendations for switching patients with highly active multiple sclerosis from other disease modifying drugs for multiple sclerosis to cladribine tablets

Por N. A. Totolyan, V. M. Alifirova, K. Z. Bakhtiyarova, A. N. Boyko, Ya. V. Vlasov, Z. A. Goncharova, M. N. Zakharova, D. S. Kasatkin, S. V. Kotov, A. I. Nilov, S. A. Sivertseva, A. A. Sokolova, N. N. Spirin, F. A. Khabirov, D. Paradnika
Publicado em 2020-10-01

Consensus of expert advices on routing, diagnosis, and management of patients with neuromyelitis optica spectrum disorders

Por A. N. Boyko, K. Z. Bakhtiyarova, L. V. Brylev, M. N. Zakharova, D. S. Kasatkin, D. S. Korobko, S. V. Kotov, V. S. Krasnov, N. A. Malkova, E. V. Popova, S. A. Sivertseva, T. O. Simaniv, A. A. Sokolova, N. A. Totolyan, T. N. Trushnikova, F. A. Khabirov, N. V. Khachanova
Publicado em 2021-10-01